Clinical Trials Browser

INDUSTRY × Classical hematology × 1 year × Clear all

NCT04256317 2026-03-18

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Hematologic Diseases, Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT04618913 2026-03-12

VICTORIE

Active not recruiting

1 enrolled

Classical hematology

Embolism, Neoplasms, Venous Thromboembolism

NCT06499285 2026-03-11

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Phase 3 Recruiting

225 enrolled

Classical hematologyMyeloid

Anemia, Myelodysplastic Syndromes

NCT05320198 2026-03-09

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

Phase 1/2 Recruiting

150 enrolled

Classical hematologyMyeloid

Anemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Primary Myelofibrosis

NCT06521931 2026-03-02

A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients

Phase 1 Completed

24 enrolled

Classical hematology

Thrombocytopenia

NCT06075030 2026-02-27

A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy

Phase 2 Not yet recruiting

36 enrolled

Classical hematology

Chemotherapy Induced Anemia

NCT06075043 2026-02-27

A Study of AND017 to Treat Cancer Related Anemia in Patients Not Receiving Chemotherapy

Phase 2 Not yet recruiting

36 enrolled

Classical hematology

Cancer-Related Anemia

NCT05589896 2026-02-24

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

Phase 1/2 Recruiting

12 enrolled

Classical hematologyDermatologicLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Hematologic Diseases, Hodgkin Disease, Leukemia, Lymphoma, Leukemia, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Cutaneous, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05171049 2026-02-23

ASTER

Phase 3 Terminated

1,150 enrolled

Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT06372717 2026-02-04

A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS

Phase 1 Recruiting

100 enrolled

Classical hematologyOther hematologic neoplasm

GATA2 Deficiency, Anemia, Refractory, with Excess of Blasts, Leukemia, Myeloid, Acute

NCT06456528 2026-01-12

QL0911 for the Treatment of Cancer Treatment-Induced Thrombocytopenia

Phase 2/3 Recruiting

235 enrolled

Classical hematology

Cancer Treatment-Induced Thrombocytopenia

NCT07205315 2025-12-26

A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia

Phase EARLY_PHASE1 Recruiting

28 enrolled

Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Hemolytic, Autoimmune, Burkitt Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT05171075 2025-12-19

MAGNOLIA

Phase 3 Active not recruiting

417 enrolled

Classical hematologyGastrointestinal

Gastrointestinal Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT06752850 2025-12-19

A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis

Phase 4 Active not recruiting

37 enrolled

Classical hematologyLymphoid

Hemophilia A, Lymphoma, Follicular, Synovitis

NCT06680752 2025-12-10

Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS

Phase 1/2 Recruiting

49 enrolled

Classical hematologyOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myeloid, Acute

NCT06906380 2025-12-08

A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies

Not yet recruiting

49 enrolled

Classical hematologyOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myeloid, Acute

NCT06711523 2025-11-25

Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy

Phase 3 Active not recruiting

250 enrolled

Classical hematology

Chemotherapy-Induced Febrile Neutropenia

NCT04582539 2025-10-22

LIMBER

Phase 1/2 Terminated

22 enrolled 28 charts

Classical hematologyMyeloidPlasma cell

Anemia, Multiple Myeloma, Myelodysplastic Syndromes

NCT03320642 2025-10-21

GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease

Phase 1 Terminated

84 enrolled

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Graft vs Host Disease, Hodgkin Disease, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms, Lymphoma, Mantle-Cell

NCT07145411 2025-08-28

HOPE

Recruiting

10 enrolled

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Aplastic, Anemia, Sickle Cell, Lymphoma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06220123 2025-07-22